Notice of Proposed Sale · 144
Tempus AI, Inc.
TEMNASDAQEQUITYCurrent
Notice of Proposed Sale
Structured filing — 144
primary_doc.xml
Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.
Proposed-sale notice
- Issuer
- Tempus AI, Inc.
- Issuer CIK
- 0001717115
- SEC file number
- 001-42130
- Phone
- 8009765448
- Person for whose account securities are to be sold
- DAVID R. EPSTEIN
- Relationships to issuer
- Director
- Street
- 600 WEST CHICAGO AVENUE, SUITE 510
- City
- CHICAGO
- State / country code
- IL
- Postal code
- 60654
Securities proposed for sale
| Security | Proposed units | Aggregate market value | Units outstanding | Approximate sale date | Exchange | Broker / market maker |
|---|---|---|---|---|---|---|
| Common | 990 | 43,431.30 | 175,390,967 | 08/03/2026 | NASDAQ | Morgan Stanley Smith Barney LLC Executive Financial Services |
Broker / market maker — proposed row 1, entry 1
- Name
- Morgan Stanley Smith Barney LLC Executive Financial Services
- Street
- 1 New York Plaza
- Street (continued)
- 8th Floor
- City
- New York
- State / country code
- NY
- Postal code
- 10004
Acquisition of securities to be sold
| Security | Acquired | Nature of acquisition | Acquired from | Amount acquired | Gift transaction | Payment date | Nature of payment |
|---|---|---|---|---|---|---|---|
| Common | 08/01/2026 | Restricted Stock Units | Issuer | 990 | N | 08/01/2026 | N/A |
Sales reported in the preceding three months
| Seller | Security | Sale date | Amount sold | Gross proceeds |
|---|---|---|---|---|
| 10b5-1 Sales for DAVID EPSTEIN | Common | 06/01/2026 | 250 | 12,350.00 |
Seller — prior-sale row 1, entry 1
- Name
- 10b5-1 Sales for DAVID EPSTEIN
- Street
- 600 WEST CHICAGO AVENUE, SUITE 510
- City
- CHICAGO
- State / country code
- IL
- Postal code
- 60654
Prior-sale reporting
- Nothing to report for the preceding three months
- N
Remarks
The securities to be sold were acquired upon the vesting of restricted stock units during the period of 8/1/2026 through 11/1/2026
Notice signature
- Notice date
- 08/03/2026
- Signed
- /s/ David R. Epstein
- Plan adoption dates
- 08/27/2024
Company context
Tempus is a technology company making precision medicine a reality through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of de-identified multimodal data and an intelligent operating system that makes that data accessible and actionable, Tempus connects AI, diagnostics and clinical workflows to deliver more personalized patient care and accelerate the discovery, development and delivery of better medicines. By continuously transforming data into insights, Tempus